-
Shabir Madhi, who is leading the South African vaccine trial, said that Africa could have a COVID-19 vaccine in the first quarter of 2021 if a clinical trial in South Africa succeeds, as reported Fidelity on Thursday.
-
The ChAdOx1 nCoV-19 experimental vaccine is also being tested in Brazil by Oxford University scientists who is working with AstraZeneca.
-
"A vaccine could be made commercial as early as the beginning of next year," Madhi said, "but it is completely dependent on the results of clinical trials."
-
Madhi noted that early results could be seen by November or December.
-
"The timing of an efficacy read-out depends on when we have around 42 COVID-19 cases at least one month after vaccination," he said.
To read more NewsPoints articles, click here.
